Fidelis Capital Partners’s Northrop Grumman NOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.16M Sell
3,168
-483
-13% -$334K 0.15% 115
2025
Q4
$2.08M Buy
3,651
+456
+14% +$265K 0.15% 116
2025
Q3
$1.95M Buy
3,195
+1,597
+100% +$906K 0.15% 115
2025
Q2
$942K Sell
1,598
-77
-5% -$37.9K 0.09% 181
2025
Q1
$793K Buy
1,675
+66
+4% +$31.5K 0.08% 184
2024
Q4
$785K Buy
1,609
+17
+1% +$8.55K 0.08% 190
2024
Q3
$822K Sell
1,592
-15
-0.9% -$7.34K 0.1% 172
2024
Q2
$787K Sell
1,607
-383
-19% -$175K 0.11% 156
2024
Q1
$953K Buy
1,990
+86
+5% +$39.6K 0.14% 134
2023
Q4
$891K Buy
1,904
+874
+85% +$410K 0.2% 106
2023
Q3
$453K Buy
1,030
+41
+4% +$18K 0.16% 143
2023
Q2
$451K Buy
989
+46
+5% +$20.9K 0.16% 141
2023
Q1
$421K Buy
+943
New +$438K 0.18% 136

Other funds holding NOC

Fidelis Capital Partners's NOC Position: Q1 2026 in Review

Fidelis Capital Partners reduced its Northrop Grumman (NOC) stake by 13% in Q1 2026, selling an estimated $334K and leaving 3,168 shares worth $2.16M. The position accounts for 0.15% of the portfolio, ranked #115.

Fidelis Capital Partners first reported a position in NOC in Q1 2023 and has held it in 13 quarters since. 1,876 funds tracked by Wall St. Rank hold NOC as of Q1 2026.

  • Fidelis Capital Partners held 3,168 shares of Northrop Grumman worth $2.16M as of Q1 2026.
  • Fidelis Capital Partners sold 483 Northrop Grumman shares in Q1 2026, an estimated $334K.
  • Northrop Grumman made up 0.15% of Fidelis Capital Partners's portfolio in Q1 2026, its #115 holding.
  • Fidelis Capital Partners first reported a position in Northrop Grumman in Q1 2023 and has held it in 13 quarters since.
  • 1,876 funds tracked by Wall St. Rank held Northrop Grumman as of Q1 2026.

Based on Fidelis Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.